Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-03-06 @ 3:00 AM
Study NCT ID:
NCT01903733
Status:
COMPLETED
Last Update Posted:
2022-07-19
First Post:
2013-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-16
First Submit QC Date:
None
Study First Post Date:
2013-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-07
Results First Submit QC Date:
None
Results First Post Date:
2021-08-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-28
Last Update Post Date:
2022-07-19
Last Update Post Date Type:
ACTUAL